Nationwide survey on the treatment policy for well-differentiated thyroid cancer - Results of a questionnaire distributed at the 37th meeting of the Japanese society of thyroid surgery

Naoyuki Shigematsu, Hiroshi Takami, Nobutake Ito, Atsushi Kubo

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The treatment policy for patients with well-differentiated thyroid cancer varies among institutions. Although surgery has been the mainstay of treatment for this cancer, there is no consensus concerning the optimal extent of thyroid resection or the extent of lymph node dissection. Furthermore, controversy remains with regard to the indications for radiation therapy and hormonal therapy in surgical or non-surgical cases and the treatment modalities for cancer recurrence. To determine the actual status of treatment policies for thyroid cancer in Japan, a questionnaire was distributed to all physicians who participated in the 37th meeting of the Japanese Society of Thyroid Surgery, to inquire into treatment options for well-differentiated thyroid cancer in relation to clinical stages in actual situations. The replies to this questionnaire were analyzed in this study.

Original languageEnglish
Pages (from-to)479-491
Number of pages13
JournalEndocrine Journal
Volume52
Issue number4
DOIs
Publication statusPublished - 2005

Fingerprint

Thyroid Neoplasms
Thyroid Gland
Therapeutics
Lymph Node Excision
Surveys and Questionnaires
Neoplasms
Japan
Radiotherapy
Physicians
Recurrence

Keywords

  • The Japanese Society of Thyroid Surgery
  • Treatment policy
  • Well-differentiated thyroid cancer

ASJC Scopus subject areas

  • Endocrinology

Cite this

@article{ee925980dc0b461480d560265d31792f,
title = "Nationwide survey on the treatment policy for well-differentiated thyroid cancer - Results of a questionnaire distributed at the 37th meeting of the Japanese society of thyroid surgery",
abstract = "The treatment policy for patients with well-differentiated thyroid cancer varies among institutions. Although surgery has been the mainstay of treatment for this cancer, there is no consensus concerning the optimal extent of thyroid resection or the extent of lymph node dissection. Furthermore, controversy remains with regard to the indications for radiation therapy and hormonal therapy in surgical or non-surgical cases and the treatment modalities for cancer recurrence. To determine the actual status of treatment policies for thyroid cancer in Japan, a questionnaire was distributed to all physicians who participated in the 37th meeting of the Japanese Society of Thyroid Surgery, to inquire into treatment options for well-differentiated thyroid cancer in relation to clinical stages in actual situations. The replies to this questionnaire were analyzed in this study.",
keywords = "The Japanese Society of Thyroid Surgery, Treatment policy, Well-differentiated thyroid cancer",
author = "Naoyuki Shigematsu and Hiroshi Takami and Nobutake Ito and Atsushi Kubo",
year = "2005",
doi = "10.1507/endocrj.52.479",
language = "English",
volume = "52",
pages = "479--491",
journal = "Endocrine Journal",
issn = "0918-8959",
publisher = "Japan Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Nationwide survey on the treatment policy for well-differentiated thyroid cancer - Results of a questionnaire distributed at the 37th meeting of the Japanese society of thyroid surgery

AU - Shigematsu, Naoyuki

AU - Takami, Hiroshi

AU - Ito, Nobutake

AU - Kubo, Atsushi

PY - 2005

Y1 - 2005

N2 - The treatment policy for patients with well-differentiated thyroid cancer varies among institutions. Although surgery has been the mainstay of treatment for this cancer, there is no consensus concerning the optimal extent of thyroid resection or the extent of lymph node dissection. Furthermore, controversy remains with regard to the indications for radiation therapy and hormonal therapy in surgical or non-surgical cases and the treatment modalities for cancer recurrence. To determine the actual status of treatment policies for thyroid cancer in Japan, a questionnaire was distributed to all physicians who participated in the 37th meeting of the Japanese Society of Thyroid Surgery, to inquire into treatment options for well-differentiated thyroid cancer in relation to clinical stages in actual situations. The replies to this questionnaire were analyzed in this study.

AB - The treatment policy for patients with well-differentiated thyroid cancer varies among institutions. Although surgery has been the mainstay of treatment for this cancer, there is no consensus concerning the optimal extent of thyroid resection or the extent of lymph node dissection. Furthermore, controversy remains with regard to the indications for radiation therapy and hormonal therapy in surgical or non-surgical cases and the treatment modalities for cancer recurrence. To determine the actual status of treatment policies for thyroid cancer in Japan, a questionnaire was distributed to all physicians who participated in the 37th meeting of the Japanese Society of Thyroid Surgery, to inquire into treatment options for well-differentiated thyroid cancer in relation to clinical stages in actual situations. The replies to this questionnaire were analyzed in this study.

KW - The Japanese Society of Thyroid Surgery

KW - Treatment policy

KW - Well-differentiated thyroid cancer

UR - http://www.scopus.com/inward/record.url?scp=25644439214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25644439214&partnerID=8YFLogxK

U2 - 10.1507/endocrj.52.479

DO - 10.1507/endocrj.52.479

M3 - Article

C2 - 16127218

AN - SCOPUS:25644439214

VL - 52

SP - 479

EP - 491

JO - Endocrine Journal

JF - Endocrine Journal

SN - 0918-8959

IS - 4

ER -